 |
Today’s biotechs and CDMOs face no shortage of challenges in their cGMP chemical supply chain operations. Unpredictable supply conditions leave many biomanufacturers facing over-taxed resources, extended lead times, and difficulties procuring essential cGMP materials. While there are many approaches to enhance the resiliency of a supply chain, the right sourcing strategy is the catalyst—protecting production schedules and accelerating critical milestones to bring biologics to market. Download this infographic to learn about:
|
